Recalls & Warnings September 05, 2014 Seller of "Nerve", "Cleanse" and Probiotic Supplements Warned for Drug Claims On July 30, 2014, the FDA issued a warning letter to Plexus Worldwide, Inc., following a review of the company's website and product labels, which found statements made about Fast Relief, BioCleanse and ProBio5 to be drug claims.
Wegovy is approved for weight management, and Mounjaro may lead to weight loss even though it is approved for type 2 diabetes
Combined, these effects might intensify but can be managed through careful monitoring and support from healthcare providers
Chromium is an essential mineral that contributes to the maintenance of normal blood glucose levels and macronutrient metabolism, helping to stabilize energy levels and reduce cravings for sugary foods
And for beginners
Mounjaro (Tirzepatide) The Game Changer Now officially licensed in Thailand Dual-action: GLP-1 and GIP receptor agonist Delivers superior appetite regulation and improved insulin sensitivity Clinical trials show up to 22.5% total body weight reduction (one of the highest across all medications) Weekly injection with flexible dosing (2.5mg15mg) Approved for Type 2 diabetes, but increasingly prescribed off-label for weight loss worldwide Unique advantage: targets two hormones , making it a potential first-choice option for patients who havent succeeded with other injectables 4